Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Hartmann

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2018
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Joanna N G Oude Elberink, Aleksandra Gorska, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Allergy|April 23, 2024
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registryMarek Niedoszytko, Aleksandra Gorska, Knut Brockow, et al.
Blood Advances|September 12, 2022
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E Kennedy, Cecelia Perkins, Andreas Reiter, et al.
NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2018
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Joanna N G Oude Elberink, Aleksandra Gorska, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Allergy|April 23, 2024
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registryMarek Niedoszytko, Aleksandra Gorska, Knut Brockow, et al.
Blood Advances|September 12, 2022
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E Kennedy, Cecelia Perkins, Andreas Reiter, et al.
NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Pageof 19